Amylyx Pharmaceuticals (AMLX) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 4, 2026, at 9:00 a.m. ET, to be held virtually.

• Proxy materials and annual report are available online for review and voting.

• Shareholders are encouraged to consent to electronic delivery to support environmental initiatives.

Voting matters and shareholder proposals

• Election of two Class II directors, each to serve until the 2029 annual meeting or until a successor is elected.

• Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory vote to approve compensation of named executive officers.

Board of directors and corporate governance

• Board recommends voting FOR all director nominees and FOR Proposals 2 and 3.